BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Oates GR, Schechter MS. Socioeconomic status and health outcomes: cystic fibrosis as a model. Expert Review of Respiratory Medicine 2016;10:967-77. [DOI: 10.1080/17476348.2016.1196140] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Bell SC, Mall MA, Gutierrez H, Macek M, Madge S, Davies JC, Burgel P, Tullis E, Castaños C, Castellani C, Byrnes CA, Cathcart F, Chotirmall SH, Cosgriff R, Eichler I, Fajac I, Goss CH, Drevinek P, Farrell PM, Gravelle AM, Havermans T, Mayer-hamblett N, Kashirskaya N, Kerem E, Mathew JL, Mckone EF, Naehrlich L, Nasr SZ, Oates GR, O'neill C, Pypops U, Raraigh KS, Rowe SM, Southern KW, Sivam S, Stephenson AL, Zampoli M, Ratjen F. The future of cystic fibrosis care: a global perspective. The Lancet Respiratory Medicine 2020;8:65-124. [DOI: 10.1016/s2213-2600(19)30337-6] [Cited by in Crossref: 183] [Cited by in F6Publishing: 82] [Article Influence: 91.5] [Reference Citation Analysis]
2 Dixon E, Puckey M, Collins N, Marsh G, Pabary R. Striving for perfection, accepting the reality: A reflection on adherence to airway clearance and inhalation therapy for paediatric patients with chronic suppurative lung disease. Paediatr Respir Rev 2020;34:46-52. [PMID: 31130423 DOI: 10.1016/j.prrv.2019.04.002] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Tumin D, Crowley EM, Li SS, Wooten W, Ren CL, Hayes D Jr. Patterns of Health Insurance Coverage and Lung Disease Progression in Adolescents and Young Adults with Cystic Fibrosis. Ann Am Thorac Soc 2021;18:290-9. [PMID: 32885982 DOI: 10.1513/AnnalsATS.201911-839OC] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
4 Mcgarry ME, Gibb ER, Oates GR, Schechter MS. Left Behind: The Potential Impact of CFTR Modulators on Racial and Ethnic Disparities in Cystic Fibrosis. Paediatric Respiratory Reviews 2021. [DOI: 10.1016/j.prrv.2021.12.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Zou X, Wang R, Yang Z, Wang Q, Fu W, Huo Z, Ge F, Zhong R, Jiang Y, Li J, Xiong S, Hong W, Liang W. Family Socioeconomic Position and Lung Cancer Risk: A Meta-Analysis and a Mendelian Randomization Study. Front Public Health 2022;10:780538. [DOI: 10.3389/fpubh.2022.780538] [Reference Citation Analysis]
6 Filigno SS, Miller J, Moore S, Peugh J, Weiland J, Backstrom J, Borschuk A. Assessing psychosocial risk in pediatric cystic fibrosis. Pediatr Pulmonol 2019;54:1391-7. [DOI: 10.1002/ppul.24414] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
7 Abbott J, Hurley MA, Chadwick H, Peckham D. Ways of coping and survival in Cystic Fibrosis: a 20-year longitudinal study. Journal of Cystic Fibrosis 2022. [DOI: 10.1016/j.jcf.2022.04.011] [Reference Citation Analysis]
8 Albon D, Bruschwein H, Soper M, List R, Jennings D, Gettle L, Compton M, Bailey M, Starheim E, Murray R, Kalmanek J, Somerville L. Impact of COVID-19 on social determinants of health for adults with cystic fibrosis. Ther Adv Respir Dis 2021;15:17534666211037459. [PMID: 34420457 DOI: 10.1177/17534666211037459] [Reference Citation Analysis]
9 Rommel AS, Milne GL, Barrett ES, Bush NR, Nguyen R, Sathyanarayana S, Swan SH, Ferguson KK. Associations between urinary biomarkers of oxidative stress in the third trimester of pregnancy and behavioral outcomes in the child at 4 years of age. Brain Behav Immun 2020;90:272-8. [PMID: 32905853 DOI: 10.1016/j.bbi.2020.08.029] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Imrie R, Ghosh S, Narvekar N, Vigneswaran K, Wang Y, Savvas M. Socioeconomic status and fertility treatment outcomes in high-income countries: a review of the current literature. Hum Fertil (Camb) 2021;:1-11. [PMID: 34315303 DOI: 10.1080/14647273.2021.1957503] [Reference Citation Analysis]
11 Zolin A, Bossi A, Cirilli N, Kashirskaya N, Padoan R. Cystic Fibrosis Mortality in Childhood. Data from European Cystic Fibrosis Society Patient Registry. Int J Environ Res Public Health 2018;15:E2020. [PMID: 30223583 DOI: 10.3390/ijerph15092020] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
12 Oates G, Rutland S, Juarez L, Friedman A, Schechter MS. The association of area deprivation and state child health with respiratory outcomes of pediatric patients with cystic fibrosis in the United States. Pediatr Pulmonol 2021;56:883-90. [PMID: 33258546 DOI: 10.1002/ppul.25192] [Reference Citation Analysis]
13 Oates GR, Schechter MS. Socioeconomic determinants of respiratory health in patients with cystic fibrosis: implications for treatment strategies. Expert Rev Respir Med 2022;:1-14. [PMID: 35705523 DOI: 10.1080/17476348.2022.2090928] [Reference Citation Analysis]
14 Blayac M, Coll P, Urbach V, Fanen P, Epaud R, Lanone S. The Impact of Air Pollution on the Course of Cystic Fibrosis: A Review. Front Physiol 2022;13:908230. [DOI: 10.3389/fphys.2022.908230] [Reference Citation Analysis]
15 Szczesniak R, Rice JL, Brokamp C, Ryan P, Pestian T, Ni Y, Andrinopoulou ER, Keogh RH, Gecili E, Huang R, Clancy JP, Collaco JM. Influences of environmental exposures on individuals living with cystic fibrosis. Expert Rev Respir Med 2020;14:737-48. [PMID: 32264725 DOI: 10.1080/17476348.2020.1753507] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
16 Tumin D, Li SS, Kopp BT, Kirkby SE, Tobias JD, Morgan WJ, Hayes D. The effect of the affordable care act dependent coverage provision on patients with cystic fibrosis. Pediatr Pulmonol 2017;52:458-66. [DOI: 10.1002/ppul.23648] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
17 Li C, Bloom MS, Lin S, Ren M, Hajat S, Wang Q, Zhang W, Ho HC, Zhao Q, Lin Y, Huang C. Temperature variation and preterm birth among live singleton deliveries in Shenzhen, China: A time-to-event analysis. Environ Res 2021;195:110834. [PMID: 33548292 DOI: 10.1016/j.envres.2021.110834] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
18 McGarry ME, Neuhaus JM, Nielson DW, Burchard E, Ly NP. Pulmonary function disparities exist and persist in Hispanic patients with cystic fibrosis: A longitudinal analysis. Pediatr Pulmonol 2017;52:1550-7. [PMID: 29082671 DOI: 10.1002/ppul.23884] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
19 Marson FAL, Bertuzzo CS, Ribeiro JD. Personalized or Precision Medicine? The Example of Cystic Fibrosis. Front Pharmacol 2017;8:390. [PMID: 28676762 DOI: 10.3389/fphar.2017.00390] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 6.2] [Reference Citation Analysis]
20 Lopes-Pacheco M. CFTR Modulators: The Changing Face of Cystic Fibrosis in the Era of Precision Medicine. Front Pharmacol 2019;10:1662. [PMID: 32153386 DOI: 10.3389/fphar.2019.01662] [Cited by in Crossref: 63] [Cited by in F6Publishing: 56] [Article Influence: 31.5] [Reference Citation Analysis]
21 Li SS, Hayes D, Tobias JD, Morgan WJ, Tumin D. Health insurance and use of recommended routine care in adults with cystic fibrosis. Clin Respir J 2018;12:1981-8. [DOI: 10.1111/crj.12767] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
22 Barengo JH, Redmann AJ, Kennedy P, Rutter MJ, Smith MM. Demographic Characteristics of Children Diagnosed with Bacterial Tracheitis. Ann Otol Rhinol Laryngol 2021;:34894211007250. [PMID: 33834902 DOI: 10.1177/00034894211007250] [Reference Citation Analysis]
23 Schlüter DK, Ostrenga JS, Carr SB, Fink AK, Faro A, Szczesniak RD, Keogh RH, Charman SC, Marshall BC, Goss CH, Taylor-Robinson D. Lung function in children with cystic fibrosis in the USA and UK: a comparative longitudinal analysis of national registry data. Thorax 2021:thoraxjnl-2021-216849. [PMID: 33975926 DOI: 10.1136/thoraxjnl-2021-216849] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Schechter MS. Comparing effectiveness and outcomes in asthma and cystic fibrosis. Paediatr Respir Rev 2017;24:24-8. [PMID: 28712576 DOI: 10.1016/j.prrv.2017.06.002] [Reference Citation Analysis]
25 Bierlaagh MC, Muilwijk D, Beekman JM, van der Ent CK. A new era for people with cystic fibrosis. Eur J Pediatr 2021;180:2731-9. [PMID: 34213646 DOI: 10.1007/s00431-021-04168-y] [Reference Citation Analysis]
26 McGarry ME, Neuhaus JM, Nielson DW, Ly NP. Regional variations in longitudinal pulmonary function: A comparison of Hispanic and non-Hispanic subjects with cystic fibrosis in the United States. Pediatr Pulmonol 2019;54:1382-90. [PMID: 31144477 DOI: 10.1002/ppul.24377] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
27 Knoppers T, Cosquer M, Hagan J, Nguyen MT, Knoppers BM. “The Stakes Are Higher”- Patient and Caregiver Perspectives on Cystic Fibrosis Research and Personalized Medicine. Front Med 2022;9:841887. [DOI: 10.3389/fmed.2022.841887] [Reference Citation Analysis]
28 Lee JA, Cho A, Huang EN, Xu Y, Quach H, Hu J, Wong AP. Gene therapy for cystic fibrosis: new tools for precision medicine. J Transl Med 2021;19:452. [PMID: 34717671 DOI: 10.1186/s12967-021-03099-4] [Reference Citation Analysis]
29 McColley SA, Martiniano SL, Ren CL, Sontag MK, Rychlik K, Balmert L, Elbert A, Wu R, Farrell PM. Disparities in first evaluation of infants with cystic fibrosis since implementation of newborn screening. J Cyst Fibros 2022:S1569-1993(22)00628-2. [PMID: 35871976 DOI: 10.1016/j.jcf.2022.07.010] [Reference Citation Analysis]